HLA-C and neoplasm: In recent years, γδT cells have attracted more attention for potential use during tumor immunotherapy because of their strong cytotoxic effect on tumor cells, lack of MHC restriction on antigen recognition, and easy expansion both in vitro and in vivo (60–62).